class name | count |
---|---|
Liliopsida | 1 |
class name | count |
---|---|
Polyangiaceae | 1 |
Araceae | 1 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00016759
![]() |
Fenozan
/ Fenoxan / Fenoksan / Phenoxan / Phenosan / Phenozan / Fenozan acid / Irganox 1310 |
![]() |
||||
C00036446
![]() |
2-(4-Hydroxyphenyl)-1-nitroethane
|
![]() |
||||
C00042069
![]() |
2,6-bis(1,1-Dimethylethyl)-4-methylphenol
|
CHEMBL146
|
D002084
|
21 / 11 / 11 | 33 / 40 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00042069 | 1 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00042069 | 4 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00042069 | 2 / 2 |
P06746 | DNA polymerase beta | Enzyme | C00042069 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00042069 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00042069 | 1 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00042069 | 0 / 1 |
P11473 | Vitamin D3 receptor | NR1I1 | C00042069 | 2 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00042069 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00042069 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00042069 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00042069 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00042069 | 0 / 0 |
P07384 | Calpain-1 catalytic subunit | C2 | C00042069 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00042069 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00042069 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00042069 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00042069 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00042069 | 0 / 1 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00042069 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00042069 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00042069
|
59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00042069
|
335 | APOA1 | apolipoprotein A-I |
C00042069
|
336 | APOA2, Apo-AII, ApoA-II, apoAII | apolipoprotein A-II |
C00042069
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00042069
|
523 | ATP6V1A, ATP6A1, ATP6V1A1, HO68, VA68, VPP2, Vma1 | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A (EC:3.6.3.14) |
C00042069
|
760 | CA2, CA-II, CAC, CAII, Car2 | carbonic anhydrase II (EC:4.2.1.1) |
C00042069
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00042069
|
4513 | COX2, COII, MTCO2, MT-CO2 | cytochrome c oxidase subunit II |
C00042069
|
1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00042069
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00042069
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00042069
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00042069
|
4018 | LPA, AK38, APOA, LP | lipoprotein, Lp(a) (EC:3.4.21.-) |
C00042069
|
7376 | NR1H2, LXR-b, LXRB, NER, NER-I, RIP15, UNR | nuclear receptor subfamily 1, group H, member 2 |
C00042069
|
10062 | NR1H3, LXR-a, LXRA, RLD-1 | nuclear receptor subfamily 1, group H, member 3 |
C00042069
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00042069
|
4968 | OGG1, HMMH, HOGG1, MUTM, OGH1 | 8-oxoguanine DNA glycosylase (EC:4.2.99.18) |
C00042069
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00042069
|
5230 | PGK1, MIG10, PGKA | phosphoglycerate kinase 1 (EC:2.7.2.3) |
C00042069
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00042069
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00042069
|
5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00042069
|
778733 |
C00042069
|
||
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00042069
|
5706 | PSMC6, CADP44, P44, SUG2, p42 | proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
C00042069
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00042069
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00042069
|
7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00042069
|
51106 | TFB1M, CGI75, mtTFB, mtTFB1 | transcription factor B1, mitochondrial (EC:2.1.1.-) |
C00042069
|
64216 | TFB2M, Hkp1, mtTFB2 | transcription factor B2, mitochondrial |
C00042069
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00042069
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00042069
|
OMIM | preferred title | UniProt |
---|---|---|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D000014 | Abnormalities, Drug-Induced |
C00042069
|
D058186 | Acute Kidney Injury |
C00042069
|
D000236 | Adenoma |
C00042069
|
D018248 | Adenoma, Liver Cell |
C00042069
|
D000435 | Alcoholic Intoxication |
C00042069
|
D001145 | Arrhythmias, Cardiac |
C00042069
|
D001649 | Bile Duct Diseases |
C00042069
|
D006528 | Carcinoma, Hepatocellular |
C00042069
|
D009202 | Cardiomyopathies |
C00042069
|
D002543 | Cerebral Hemorrhage |
C00042069
|
D003110 | Colonic Neoplasms |
C00042069
|
D003876 | Dermatitis, Atopic |
C00042069
|
D056486 | Drug-Induced Liver Injury |
C00042069
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00042069
|
D020964 | Embryo Loss |
C00042069
|
D005355 | Fibrosis |
C00042069
|
D005770 | Gastrointestinal Neoplasms |
C00042069
|
D006130 | Growth Disorders |
C00042069
|
D006331 | Heart Diseases |
C00042069
|
D006402 | Hematologic Diseases |
C00042069
|
D006470 | Hemorrhage |
C00042069
|
D006474 | Hemorrhagic Disorders |
C00042069
|
D006529 | Hepatomegaly |
C00042069
|
D006965 | Hyperplasia |
C00042069
|
D006967 | Hypersensitivity |
C00042069
|
D007674 | Kidney Diseases |
C00042069
|
D007683 | Kidney Tubular Necrosis, Acute |
C00042069
|
D008113 | Liver Neoplasms |
C00042069
|
D008175 | Lung Neoplasms |
C00042069
|
D008325 | Mammary Neoplasms, Experimental |
C00042069
|
D009336 | Necrosis |
C00042069
|
D009369 | Neoplasms |
C00042069
|
D010190 | Pancreatic Neoplasms |
C00042069
|
D010212 | Papilloma |
C00042069
|
D011014 | Pneumonia |
C00042069
|
D011230 | Precancerous Conditions |
C00042069
|
D011297 | Prenatal Exposure Delayed Effects |
C00042069
|
D011507 | Proteinuria |
C00042069
|
D013964 | Thyroid Neoplasms |
C00042069
|
D001749 | Urinary Bladder Neoplasms |
C00042069
|